 |
市場調查報告書
商品編碼
1873977
3D列印藥物市場3D Printed Drugs Market |
||||||
預計3D列印藥物市場將從2024年的3,680萬美元成長到2031年的8,308萬美元，2031年至2031年期間的年複合成長率（CAGR）為9.6%。採用創新技術進行3D藥物列印以提高治療效果的趨勢預計將成為市場發展的重要因素。
3D列印藥物市場分析
3D列印藥物是指利用3D列印技術製造的藥品，該技術將數位檔案轉化為3D實體。這類藥物在個人化醫療領域至關重要，有助於探索客製化的藥物釋放曲線。這需要一個數位檔案來指定所需的藥物釋放特性，包括藥物濃度、釋放速率和動力學、時間依賴性釋放曲線以及材料屬性。這些進步使得精準給藥的個人化醫療成為可能，從而提高療效、改善患者依從性並最大限度地減少副作用。
3D列印藥物市場概覽
3D列印藥物是指利用3D列印技術生產的藥品，該技術能夠精確製造複雜的結構並客製化劑量。這種方法具有許多優勢，包括個人化醫療、複雜幾何形狀的製造、快速原型製作、按需生產以及增強藥物輸送。 Spritam和ZipDose就是3D列印藥物的例子。市場擴張的促進因素包括人們對3D列印技術的認知度不斷提高以及3D列印研究的顯著進步。然而，非法藥物製造的潛在風險可能會在預測期內對市場成長產生負面影響。
戰略洞察
3D列印藥物市場的促進因素與機會
吞嚥困難發病率上升將有利於市場
全球人口持續成長，預計到2050年，65歲以上人口將達到20億，其中85歲以上人口尤為突出。流行病學研究表明，吞嚥困難在老年人和兒童中普遍存在。根據美國疾病管制與預防中心（CDC）的資料顯示，美國每年有超過79.5萬人發生中風，其中50%的患者伴隨吞嚥障礙。此外，多種神經系統疾病也與吞嚥困難有關。 3D列印藥物的多孔特性使其能夠在口腔內快速崩解，因此非常適合吞嚥困難的患者，從而推動了預測期內的市場成長。
發展中國家的新興市場
3D列印技術正被應用於包括時尚、建築和航太在內的各個領域。在醫學領域，它主要應用於牙科和組織工程，而其在製藥領域的應用則相對較新。許多產業正在利用3D列印的潛力，專家認為，3D列印（3DP）藥物將在未來幾年改變製藥業的格局。精準醫療具有巨大的潛力，可以為每位患者量身訂做劑量。眾多製藥公司體認到，在開發滿足特定患者需求的劑型方面，3D列印技術蘊藏著巨大的機會和靈活性。例如，總部位於辛辛那提的Aprecia公司專注於3D列印藥品。此外，2020年2月，默克公司和德國施塔恩貝格的AMCM公司宣布合作開發3D列印片劑。預計此類合作將在預測期內為3D列印藥物生產商創造豐厚的利潤空間。
3D列印藥物市場細分分析
對 3D 列印藥物市場進行分析的關鍵細分市場包括類型、應用和最終用戶。
- 依樹脂類型分類，市場可分為片劑、膠囊、多重藥物植入劑、奈米顆粒、溶液和其他劑型。 2023年，片劑佔據最大的市場佔有率，預計在預測期內將保持最高的複合年成長率。
- 從技術類型來看，市場可分為噴墨列印、直接寫入、快速劑量列印、熱噴墨列印、熔融沈積成型、粉末床列印、立體光刻（SLA）和半固態擠出（SSE）。 2023年，快速劑量列印佔據了最大的市場佔有率。
3D列印藥物市場的地理分析
3D列印藥物市場的地理分析將市場分類為五個區域：北美、亞太、歐洲、中東和非洲以及南美和中美洲。北美在3D列印藥物市場中處於領先地位，這主要得益於政府和私人對醫療基礎設施投資的增加、人們對這類藥物認知度的提高以及製藥行業技術的進步。眾多公司正大力投資研發，以透過重大的產品創新和發展來促進市場成長。策略夥伴關係和合作正成為市場拓展的有效途徑，能夠充分利用各公司多元化的技能和專業知識。例如，研究和醫療實驗室公司Organovo正在引領美國3D生物列印領域的研發。此外，該公司於2020年初向美國食品藥物管理局（FDA）提交了其生物列印肝組織用於治療罕見疾病的IND申請。
3D列印藥物市場報告範圍（請將此關鍵字保留在此處，以便Shyam查看）
請勿在此處新增任何表格
“
3D列印藥物市場的最新發展
對3D列印藥物市場的評估是基於從一手和二手研究中獲得的定性和定量資料，包括重要的企業出版物、協會資料和資料庫。以下是該市場在創新、業務擴張和策略方面的最新發展：
- 2023年10月，芬蘭醫療科技公司CurifyLabs宣布推出全球首款符合GMP（藥品生產品質管理規範）標準的3D列印藥品專用墨水。據該公司稱，CurifyLabs的藥品工具包包含自動化3D列印技術和可列印藥品專用墨水，旨在促進個人化醫療的更廣泛應用，從而改善未來不同需求患者的醫療服務。 （資料來源：CurifyLabs，新聞稿）
- 2023年9月，立陶宛健康科學大學（LSMU）推出了首台經認證的製藥3D列印機。這項新技術標誌著製藥技術創新取得了重大進展，它能夠生產針對個別患者的個人化藥物，透過將多種成分組合在單片藥片中來提高藥物療效，並減少副作用。 （資料來源：立陶宛健康科學大學，新聞稿）
3D列印藥物市場報告的覆蓋範圍和交付成果
這份題為《3D列印藥物市場規模及預測（2021-2031）》的報告對市場進行了全面分析，涵蓋以下領域：
- 3D列印藥物市場規模及預測，涵蓋全球、區域和國家層面的所有關鍵細分市場。
- 市場動態，例如促進因素、限制因素和關鍵機會
- 3D列印藥物市場趨勢
- 詳細的PEST和SWOT分析
- 對 3D 列印藥物市場進行分析，涵蓋關鍵趨勢、全球和區域框架、主要參與者、法規和近期市場發展。
- 3D列印藥物市場的產業格局和競爭分析，包括市場集中度、熱圖分析、主要參與者和最新發展。
- 深入的公司概況。
目錄
第1章：引言
第2章：3D列印藥物市場及主要結論
第3章：研究方法
- 覆蓋範圍
- 二手研究
- 初步研究
第4章：全球3D列印藥物市場及市場概況
- 概述
- 害蟲分析
- 北美和PEST分析
- 歐洲和PEST分析
- 亞太地區及PEST分析
- 中東和非洲以及 PEST 分析
- 南美洲和中美洲以及 PEST 分析
第5章：全球3D列印藥物市場及主要市場動態
- 市場促進因素
- 個人化藥物應用日益普及
- 吞嚥困難盛行率不斷上升
- 市場限制
- 利用3D列印技術製造非法毒品
- 市場機遇
- 人們對3D列印技術的認知不斷提高
- 未來趨勢
- 採用新技術進行3D藥物列印，以簡化流程並取得良好效果
- 影響分析
第6章：3D列印藥物市場及全球分析
- 全球3D列印藥物市場收入預測與分析
- 全球3D列印藥物市場（依地理分類）－預測與分析
- 關鍵參與者的市場定位
第7章：3D列印藥物市場分析及劑型分析
- 概述
- 2024 年及 2031 年 3D 列印藥物市佔率（以劑型分類，%）
- 片劑
- 膠囊
- 多重植入物
- 奈米顆粒
- 解決方案
- 其他劑型
第8章：3D列印藥物市場分析及技術分類
- 概述
- 按技術分類的3D列印藥物市場佔有率，2024年和2031年（%）
- 噴墨列印
- 直接寫入
- Zip Dose
- 熱噴墨列印
- 熔融沈積成型
- 粉末床列印
- 立體光刻（SLA）
- 半固態擠出（SSE）
第9章：3D列印藥物市場及地理分析
- 北美洲
- 美國
- 加拿大
- 墨西哥
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 南美洲和中美洲
- 巴西
- 阿根廷
第10章：新冠肺炎疫情對全球罕見神經系統疾病治療市場的影響
- 北美洲
- 歐洲
- 亞太
- 世界其他地區
第11章：3D列印藥物市場與產業概況
- 概述
- 市場中各公司採取的成長策略（%）
- 有機發展
- 概述
- 無機物發展
- 概述
第12章：公司簡介
- GlaxoSmithKline plc.
- Aprecia Pharmaceuticals, LLC.
- AstraZeneca
- FabRx Ltd
- Merck KGaA
- Cycle Pharmaceuticals
- Tvasta
- MSD
第13章：附錄
The 3D Printed Drugs Market is anticipated to grow from US$ 36.80 million in 2024 to US$ 83.08 million by 2031, reflecting a compound annual growth rate (CAGR) of 9.6% during the period from 2031 to 2031. The trend towards adopting innovative technologies in 3D drug printing to enhance procedural outcomes is expected to be a significant factor in the market's development.
Analysis of the 3D Printed Drugs Market
A 3D printed drug is a pharmaceutical product created through 3D printing technology, which transforms a digital file into a three-dimensional solid. These drugs are crucial in the realm of personalized medicine, facilitating the exploration of customized drug release profiles. This involves a digital file that specifies the desired drug release characteristics, including drug concentration, release rate and kinetics, time-dependent release profile, and material properties. Such advancements enable the creation of personalized medicine with accurate drug delivery, leading to enhanced efficacy, improved patient adherence, and minimized side effects.
Overview of the 3D Printed Drugs Market
3D printed drugs are pharmaceuticals produced using 3D printing technology, which allows for the precise creation of intricate structures and tailored dosages. This method provides numerous advantages, including personalized medicine, complex geometries, rapid prototyping, on-demand production, and enhanced drug delivery. Examples of 3D-printed drugs include Spritam and ZipDose. The market's expansion is driven by factors such as increasing awareness of 3D printing and significant advancements in 3D printing research. However, the potential for illegal drug manufacturing may negatively impact market growth during the forecast period.
Strategic Insights
Drivers and Opportunities in the 3D Printed Drugs Market
Rising Incidence of Dysphagia to Benefit the Market
The global population is on the rise, with projections indicating that by 2050, there will be 2 billion individuals aged 65 and older, particularly among those over 85. Epidemiological studies show that dysphagia is prevalent in older adults and children. According to CDC data, over 795,000 individuals in the US suffer strokes annually, with 50% experiencing swallowing disorders. Additionally, various neurological conditions are linked to dysphagia. The porous nature of 3D-printed drugs allows them to disintegrate easily in the mouth, making them suitable for patients with swallowing difficulties, thus propelling market growth during the forecast period.
Emerging Markets in Developing Nations
3D printing technologies are being utilized across various sectors, including fashion, construction, and aerospace. In medicine, they are primarily applied in dentistry and tissue engineering, while their use in pharmaceuticals is relatively new. Many industries are harnessing the potential of 3D printing, and experts believe that 3D printed (3DP) medications will transform the pharmaceutical landscape in the coming years. There is significant potential for precision medicine to customize dosages for individual patients. Numerous pharmaceutical companies recognize the vast opportunities and flexibility in creating dosage forms tailored to specific patient requirements. For example, Aprecia, based in Cincinnati, specializes in 3DP medicinal products. Furthermore, in February 2020, Merck and AMCM from Starnberg, Germany, announced a partnership to develop 3D printed tablets. Such initiatives are expected to create lucrative opportunities for manufacturers of 3D-printed drugs in the forecast period.
Segmentation Analysis of the 3D Printed Drugs Market
Key segments contributing to the analysis of the 3D printed drugs market include type, application, and end user.
- By resin type, the market is categorized into tablets, capsules, multi-drug implants, nanoparticles, solutions, and other dosage forms. The tablet segment accounted for the largest market share in 2023 and is projected to exhibit the highest CAGR during the forecast period.
- In terms of technology type, the market is divided into inkjet printing, direct write, zip dose, thermal inkjet printing, fused deposition modeling, powder bed printing, stereolithography (SLA), and semi-solid extrusion (SSE). The zip dose segment held the largest market share in 2023.
Geographical Analysis of the 3D Printed Drugs Market
The geographical analysis of the 3D printed drugs market is segmented into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. North America leads the 3D printed drugs market, driven by increased government and private investment in healthcare infrastructure, heightened awareness of these drugs, and advancements in technology within the pharmaceutical sector. Numerous companies are investing heavily in R&D to foster market growth through significant product innovations and developments. The market is witnessing strategic partnerships and collaborations as a promising avenue for expanding market presence by leveraging the diverse skills and expertise of various companies. For instance, Organovo, a research and medical laboratory firm, is pioneering R&D in 3D bioprinting in the country. Additionally, the company approached the FDA in early 2020 with an IND application for its bio-printed liver tissue aimed at treating rare diseases.
Scope of the 3D Printed Drugs Market Report (KEEP THIS KEYWORD HERE FOR SHYAM)
“DO NOT ADD ANY TABLE HERE
”
Recent Developments in the 3D Printed Drugs Market
The evaluation of the 3D printed drugs market is based on qualitative and quantitative data obtained from primary and secondary research, including significant corporate publications, association data, and databases. Below are recent developments in the market regarding innovations, business expansions, and strategies:
- In October 2023, Finnish healthtech company CurifyLabs announced the launch of the world's first GMP (good manufacturing practice) produced Pharma Inks for 3D printable medicines. CurifyLabs' Pharma Kit, which includes automated 3D printing technology and printable pharmaceutical inks, aims to facilitate the broader adoption of personalized medicine, enhancing future care for patients with diverse needs, according to the company. (Source: CurifyLabs, Press Release)
- In September 2023, LSMU (Lithuanian University of Health Sciences) introduced the first validated pharmaceutical 3D printer. This new device marks a significant advancement in pharmaceutical technology innovation, enabling the production of personalized medicine tailored to individual patients, improving drug efficacy by combining multiple substances in a single tablet, and reducing side effects. (Source: LSMU, Press Release)
Coverage and Deliverables of the 3D Printed Drugs Market Report
The report titled "3D Printed Drugs Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas:
- 3D Printed Drugs Market size and forecast at global, regional, and country levels for all key market segments included in the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Trends in the 3D Printed Drugs Market
- Detailed PEST and SWOT analysis
- Analysis of the 3D Printed Drugs Market covering key trends, global and regional frameworks, major players, regulations, and recent market developments.
- Industry landscape and competition analysis of the 3D Printed Drugs Market, including market concentration, heat map analysis, prominent players, and recent developments.
- In-depth company profiles.
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Global 3D Printed Drugs Market and By Dosage Forms
- 1.3.2 Global 3D Printed Drugs Market and By Technology
- 1.3.3 Global 3D Printed Drugs Market and By Geography
2. 3D Printed Drugs Market and Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Global 3D Printed Drugs Market and Market Landscape
- 4.1 Overview
- 4.2 Pest Analysis
- 4.2.1 North America and PEST Analysis
- 4.2.2 Europe and PEST Analysis
- 4.2.3 Asia Pacific and PEST Analysis
- 4.2.4 Middle East and Africa and PEST Analysis
- 4.2.5 South and Central America and PEST Analysis
5. Global 3D Printed Drugs market and Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Increasing Adoption of Personalized Drugs
- 5.1.2 Increasing Prevalence of Dysphagia
- 5.2 Market Restraints
- 5.2.1 Usage of 3D Printing to Develop Illegal Drugs
- 5.3 Market Opportunities
- 5.3.1 Rising Awareness About the 3D Printing Technology
- 5.4 Future Trends
- 5.4.1 Adoption of Novel Technologies in 3D Drugs Printing to Streamline Procedural Outcomes
- 5.5 Impact analysis
6. 3D Printed Drugs Marketand Global Analysis
- 6.1 Global 3D Printed Drugs Market Revenue Forecast And Analysis
- 6.2 Global 3D Printed Drugs Market, By Geography - Forecast And Analysis
- 6.3 Market Positioning of Key Players
7. 3D Printed Drugs Market Analysis and By Dosage Forms
- 7.1 Overview
- 7.2 3D Printed Drugs Market Share, by Dosage Forms, 2024 and 2031, (%)
- 7.3 Tablets
- 7.3.1 Overview
- 7.3.2 Tablets: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 7.3.3 Tablets: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 7.4 Capsules
- 7.4.1 Overview
- 7.4.2 Capsules: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 7.5 Multi Drug Implant
- 7.5.1 Overview
- 7.5.2 Multi Drug Implant: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 7.6 Nanoparticles
- 7.6.1 Overview
- 7.6.2 Nanoparticles: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 7.7 Solutions
- 7.7.1 Overview
- 7.7.2 Solutions: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 7.8 Other Dosage Forms
- 7.8.1 Overview
- 7.8.2 Other Dosage Forms: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
8. 3D Printed Drugs Market Analysis and By Technology
- 8.1 Overview
- 8.2 3D Printed Drugs Market Share, by Technology, 2024 and 2031 (%)
- 8.3 Inkjet Printing
- 8.3.1 Overview
- 8.3.2 Inkjet Printing: 3D Printed Drugs Marketand Revenue and Forecast to 2031 (US$ Thousands)
- 8.4 Direct Write
- 8.4.1 Overview
- 8.4.2 Direct Write: 3D Printed Drugs Marketand Revenue and Forecast to 2031 (US$ Thousands)
- 8.5 Zip Dose
- 8.5.1 Overview
- 8.5.2 Zip Dose: 3D Printed Drugs Marketand Revenue and Forecast to 2031 (US$ Thousands)
- 8.5.3 Zip Dose: 3D Printed Drugs Marketand Revenue and Forecast to 2031 (US$ Thousands)
- 8.6 Thermal Inkjet Printing
- 8.6.1 Overview
- 8.6.2 Thermal Inkjet: 3D Printed Drugs Marketand Revenue and Forecast to 2031 (US$ Thousands)
- 8.7 Fused Deposition Modelling
- 8.7.1 Overview
- 8.7.2 Fused Deposition Modelling: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 8.8 Powder Bed Printing
- 8.8.1 Overview
- 8.8.2 Powder Bed Printing: 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 8.9 Stereolithography (SLA)
- 8.9.1 Overview
- 8.9.2 Stereolithography (SLA): 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
- 8.10 Semi Solid Extrusion (SSE)
- 8.10.1 Overview
- 8.10.2 Semi Solid Extrusion (SSE): 3D Printed Drugs Market and Revenue and Forecast to 2031 (US$ Thousands)
9. 3D Printed Drugs Market and Geographic Analysis
- 9.1 North America: 3D Printed Drugs Market
- 9.1.1 Overview
- 9.1.2 North America: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.1.3 North America: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.1.4 North America: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.1.5 North America: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.1.6 North America: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.1.7 North America: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.1.8 North America: 3D Printed Drugs Market, by Country, 2031 and 2031 (%)
- 9.1.9 US: 3D Printed Drugs Market and Revenue and Forecast (USD thousands)
- 9.1.9.1 US: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.1.9.2 US: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.1.9.3 US: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.1.9.4 US: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.1.9.5 US: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.1.9.6 US: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.1.10 Canada: 3D Printed Drugs Market and Revenue and Forecast (USD Thousands)
- 9.1.10.1 Canada: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.1.10.2 Canada: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.1.10.3 Canada: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.1.11 Mexico: 3D Printed Drugs Market and Revenue and Forecast (USD thousands)
- 9.1.11.1 Mexico: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.1.11.2 Mexico: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.1.11.3 Mexico: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.2 Europe: 3D Printed Drugs Market
- 9.2.1 Overview
- 9.2.2 Europe: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.2.3 Europe: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.2.4 Europe: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.2.5 Europe: 3D Printed Drugs Market, by Country, 2024 and 2031 (%)
- 9.2.6 Germany: 3D Printed Drugs Market
- 9.2.6.1 Germany: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.2.6.2 Germany: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.2.6.3 Germany: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.2.7 United Kingdom: 3D Printed Drugs Market
- 9.2.7.1 United Kingdom: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.2.7.2 United Kingdom: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.2.7.3 United Kingdom: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.2.8 France: 3D Printed Drugs Market
- 9.2.8.1 France: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.2.8.2 France: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.2.8.3 France: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.2.9 Italy: 3D Printed Drugs Market
- 9.2.9.1 Italy: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.2.9.2 Italy: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.2.9.3 Italy: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.2.10 Spain: 3D Printed Drugs Market
- 9.2.10.1 Spain: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.2.10.2 Spain: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.2.10.3 Spain: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.3 Asia Pacific: 3D Printed Drugs Market
- 9.3.1 Overview
- 9.3.2 Asia Pacific: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.3.3 Asia Pacific: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.3.4 Asia Pacific: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.3.5 Asia Pacific: 3D Printed Drugs Market, by Country, 2024 and 2031 (%)
- 9.3.6 China: 3D Printed Drugs Market
- 9.3.6.1 China: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.3.6.2 China: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.3.6.3 China: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.3.7 Japan: 3D Printed Drugs Market
- 9.3.7.1 Japan: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.3.7.2 Japan: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.3.7.3 Japan: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.3.8 India: 3D Printed Drugs Market
- 9.3.8.1 India: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.3.8.2 India: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.3.8.3 India: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.3.9 South Korea: 3D Printed Drugs Market
- 9.3.9.1 South Korea: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.3.9.2 South Korea: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.3.9.3 South Korea: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.3.10 Australia: 3D Printed Drugs Market
- 9.3.10.1 Australia: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.3.10.2 Australia: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.3.10.3 Australia: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.4 Middle East and Africa: 3D Printed Drugs Market
- 9.4.1 Overview
- 9.4.2 Middle East and Africa: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.4.3 Middle East and Africa: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.4.4 Middle East and Africa: 3D Printed Drugs Market, by Country, 2024 and 2031 (%)
- 9.4.5 Saudi Arabia: 3D Printed Drugs Market
- 9.4.5.1 Saudi Arabia: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.4.5.2 Saudi Arabia: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.4.5.3 Saudi Arabia: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.4.6 South Africa: 3D Printed Drugs Market
- 9.4.6.1 South Africa: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.4.6.2 South Africa: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.4.6.3 South Africa: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.4.7 UAE: 3D Printed Drugs Market
- 9.4.7.1 UAE: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.4.7.2 UAE: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.4.7.3 UAE: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.5 South and Central America: 3D Printed Drugs Market
- 9.5.1 Overview
- 9.5.2 South and Central America: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.5.3 South and Central America: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.5.4 South and Central America: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.5.5 South and Central America: 3D Printed Drugs Market, by Country, 2024 and 2031 (%)
- 9.5.6 Brazil: 3D Printed Drugs Market
- 9.5.6.1 Brazil: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.5.6.2 Brazil: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.5.6.3 Brazil: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
- 9.5.7 Argentina: 3D Printed Drugs Market
- 9.5.7.1 Argentina: 3D Printed Drugs Market and Revenue and Forecast to 2031 (USD Thousands)
- 9.5.7.2 Argentina: 3D Printed Drugs Market, by Dosage Forms, 2024 and 2031 (USD Thousands)
- 9.5.7.3 Argentina: 3D Printed Drugs Market, by Technology, 2024 and 2031 (USD Thousands)
10. Impact Of COVID-19 Pandemic On Global Rare Neurological Diseases Treatment Market
- 10.1 North America: Impact Assessment of COVID-19 Pandemic
- 10.2 Europe: Impact assessment of COVID-19 Pandemic
- 10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
- 10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
11. 3D Printed Drugs Market andIndustry Landscape
- 11.1 Overview
- 11.2 Growth Strategies Done by the Companies in the Market, (%)
- 11.3 Organic Developments
- 11.3.1 Overview
- 11.4 Inorganic Developments
- 11.4.1 Overview
12. Company Profiles
- 12.1 GlaxoSmithKline plc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Aprecia Pharmaceuticals, LLC.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 AstraZeneca
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 Key Developments
- 12.4 FabRx Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Merck KGaA
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Cycle Pharmaceuticals
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Tvasta
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 MSD
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
